Myostatin Propeptide

Myostatin inhibitor · Also known as GDF-8 Propeptide, Myostatin Inhibitor Peptide

What is Myostatin Propeptide?

The natural propeptide region of myostatin that, when administered exogenously, binds to and inhibits mature myostatin, removing the body's natural brake on muscle growth.

Myostatin (GDF-8) normally limits muscle growth. Its own propeptide domain remains bound to the mature protein after cleavage, keeping it inactive. Exogenous myostatin propeptide can overwhelm this system and inhibit circulating myostatin.

Key takeaway: Myostatin propeptide is a natural inhibitor of the body's muscle growth brake, but translating animal results to humans has proven challenging.

Benefits & evidence

Muscle growth Preliminary confidence

How it works

Myostatin is secreted as a precursor protein. After processing, the propeptide region remains non-covalently associated with the mature growth factor, keeping it latent. By flooding the system with additional propeptide, more circulating myostatin can be trapped in its inactive form.

In animal studies, myostatin knockout or inhibition leads to dramatic muscle hypertrophy (the 'double muscled' phenotype seen in Belgian Blue cattle). However, replicating these effects with exogenous propeptide in humans has been difficult due to dosing and delivery challenges.

Dosing information

Typical dosing protocol
Starting dose

Not well established

Maintenance dose

Not well established


No standardized human dosing protocol. Animal research only.

Side effects

Most side effects tend to improve as your body adjusts.

Unknown in humans Moderate

Research (10 studies)

Dynamic Anchoring of Peptides to the Extracellular Matrix Enabled by Boronic Acid. Chembiochem : a European journal of chemical biology · 2025